AWM
VRTX icon

Accurate Wealth Management’s Vertex Pharmaceuticals VRTX Stock Holding History

Accurate Wealth Management’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$658K Buy
1,356
+154
+13% +$68.3K 0.06% 294
2026
Q1 		$525K Sell
1,202
-60
-5% -$28K 0.06% 303
2025
Q4 		$586K Buy
1,262
+83
+7% +$35.8K 0.07% 272
2025
Q3 		$486K Buy
1,179
+135
+13% +$56.4K 0.06% 297
2025
Q2 		$500K Sell
1,044
-385
-27% -$177K 0.08% 266
2025
Q1 		$692K Buy
1,429
+512
+56% +$239K 0.13% 159
2024
Q4 		$375K Buy
917
+56
+7% +$26K 0.07% 247
2024
Q3 		$417K Buy
861
+335
+64% +$161K 0.08% 233
2024
Q2 		$258K Buy
+526
New +$228K 0.06% 260
2024
Q1 		– Sell
-555
Closed -$239K – 307
2023
Q4 		$239K Buy
+555
New +$205K 0.07% 240
2023
Q1 		– Sell
-421
Closed -$122K – 1436
2022
Q4 		$122K Buy
+421
New +$128K 0.04% 277
2022
Q1 		– Sell
-1,396
Closed -$262K – 194
2021
Q4 		$262K Buy
1,396
+50
+4% +$9.72K 0.21% 116
2021
Q3 		$244K Buy
1,346
+216
+19% +$42.2K 0.21% 117
2021
Q2 		$228K Buy
+1,130
New +$236K 0.2% 120

Other funds holding VRTX

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
BHIA
Birch Hill Investment Advisors Boston, Massachusetts $2.47B AUM 20.95% 1-Year Est. Return
CTB
Country Trust Bank Bloomington, Illinois $5.71B AUM 25.48% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return
GIA
Gateway Investment Advisers Cincinnati, Ohio $10.1B AUM 40.26% 1-Year Est. Return
II
IFM Investors Melbourne, Australia $15.1B AUM 40.57% 1-Year Est. Return

Accurate Wealth Management's VRTX Position: Q2 2026 in Review

Accurate Wealth Management increased its Vertex Pharmaceuticals (VRTX) stake by 13% in Q2 2026, buying an estimated $68.3K and bringing the position to 1,356 shares worth $658K. The position accounts for 0.06% of the portfolio, ranked #294.

Accurate Wealth Management first reported a position in VRTX in Q2 2021 and has held it in 14 quarters since. The position peaked at $692K in Q1 2025. 334 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • Accurate Wealth Management held 1,356 shares of Vertex Pharmaceuticals worth $658K as of Q2 2026.
  • Accurate Wealth Management bought 154 Vertex Pharmaceuticals shares in Q2 2026, an estimated $68.3K.
  • Vertex Pharmaceuticals made up 0.06% of Accurate Wealth Management's portfolio in Q2 2026, its #294 holding.
  • Accurate Wealth Management first reported a position in Vertex Pharmaceuticals in Q2 2021 and has held it in 14 quarters since.
  • Accurate Wealth Management's Vertex Pharmaceuticals position peaked at $692K in Q1 2025.
  • 334 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Accurate Wealth Management's 13F filing for Q2 2026, filed 15 Jul 2026.